Questions about this study?
The HopeStage team will email you.
TerminatedNCT06648655
A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Addiction
Researchers are comparing TMP-301 and placebo, tracking side effects to assess safety and tolerability in adults with alcohol dependence.
Medication studyAges 18–65United States
Understand this study
What is this study about?
Researchers are comparing TMP-301 and placebo, tracking side effects to assess safety and tolerability in adults with alcohol dependence.
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- Scottsdale and 13 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: November 14, 2024
- Recruitment status
- Terminated
- Enrollment listed in the registry
- 110
- Sponsor
- Tempero Bio, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT06648655
- Official title
Show the full official title
A Phase 2, Randomized, Investigator and Participant bLInded, placeBo-controllEd, paRallel-group Study to Investigate the sAfety, Tolerability, and Preliminary Efficacy of TMP-301 TrEatment in Adult Patients With Alcohol Use Disorder (AUD)
Recruitment & locations
TerminatedScottsdale · New Haven · Hollywood
11 more locations
- Jacksonville
- Lauderhill
- Orlando
- Decatur
- Savannah
- Mandeville
- Albuquerque
- Cedarhurst
- Charleston
- Houston
- Charlottesville
A listed location does not confirm current availability.
Questions about this study
What is this study about?
Researchers are comparing TMP-301 and placebo, tracking side effects to assess safety and tolerability in adults with alcohol dependence.
Who is behind this study?
The study sponsor is Tempero Bio, Inc.
Does this study involve medication?
Yes. The study involves medication, including TMP-301 and Placebo.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as terminated.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me